InVivo Therapeutics soars 15% on FDA acceptance of preclinical module for HDE submission
July 13 2021 - 11:02AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Mar 2024 to Apr 2024
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2023 to Apr 2024